Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations

Medicine, Cardiology, Otolaryngology +10

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Paul M. Ridker, Mary Cushman, Meir J. Stampfer et al. · New England Journal of Medicine · 1997 · 5.5K citations · Full text

Medicine, Cardiology, Preventive Medicine +12

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Aruna D. Pradhan · JAMA · 2001 · 4.4K citations

Veterinary Medicine, Immunology, Disease Prevention +12

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Paul M. Ridker, Nader Rifai, Lynda Rose et al. · New England Journal of Medicine · 2002 · 3.6K citations · Full text

Medicine, Gynecology, High-risk Pregnancy +3